Literature DB >> 22716238

Changes in circulating biomarkers during a single hemodialysis session.

Tae Yamamoto1, Marcelo M Nascimento, Shirley Y Hayashi, Abdul Rashid Qureshi, Jacek Waniewski, Lars Åke Brodin, Björn Anderstam, Britta Lind, Miguel C Riella, Astrid Seeberger, Bengt Lindholm.   

Abstract

The hemodialysis (HD) procedure induces an inflammatory response potentially contributing to cardiovascular disease. Here we investigated the acute impact of HD on circulating biomarkers. Circulating biomarkers (small solutes, middle molecular-sized peptides, and proteins) related to inflammation, oxidative stress, and vascular calcification (VC) were measured before and after a single session of HD in 45 clinically stable patients. Concentrations were corrected for ultrafiltration-induced hemoconcentration. Among vascular calcification-related biomarkers, osteoprotegerin and fetuin-A remained unchanged while fibroblast growth factor-23 (FGF23) decreased by -19%. Changes of FGF23 and changes of phosphate correlated (ρ = 0.61, P < 0.001). While C-reactive protein did not change, interleukin-6 (IL-6) increased by 14% and pentraxin 3 (PTX3) increased by 45%. IL-6 and PTX3 appear to be valid biomarkers of the intradialytic inflammatory response. VC-related markers were in general not affected by the single HD session; however, the observed correlation between acute changes of FGF-23 and phosphate during HD warrants further studies.
© 2012 The Authors. Hemodialysis International © 2012 International Society for Hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22716238     DOI: 10.1111/j.1542-4758.2012.00720.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  17 in total

1.  Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study.

Authors:  Valeria Cernaro; Silvia Lucisano; Valeria Canale; Annamaria Bruzzese; Daniela Caccamo; Giuseppe Costantino; Michele Buemi; Domenico Santoro
Journal:  J Nephrol       Date:  2017-04-11       Impact factor: 3.902

Review 2.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

Review 3.  Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

Authors:  Srisakul Chirakarnjanakorn; Sankar D Navaneethan; Gary S Francis; W H Wilson Tang
Journal:  Int J Cardiol       Date:  2017-01-04       Impact factor: 4.164

4.  A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients?

Authors:  Nicola Tessitore; Albino Poli; Valeria Bedogna; Luca Corazza; Natascia Campostrini; Mauro Atti; Luisa Sereni; Annalisa Castagna; Domenico Girelli; Giuseppina Pessolano; Antonio Lupo
Journal:  J Nephrol       Date:  2017-03-28       Impact factor: 3.902

Review 5.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

6.  Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities.

Authors:  Louise Schilder; S Azam Nurmohamed; Pieter M ter Wee; Nanne J Paauw; Armand R J Girbes; Albertus Beishuizen; Robert H J Beelen; A B Johan Groeneveld
Journal:  BMC Nephrol       Date:  2015-10-30       Impact factor: 2.388

7.  Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.

Authors:  Ping Jia; Wei Jin; Jie Teng; Hao Zhang; Jianzhou Zou; Zhonghua Liu; Bo Shen; Xuesen Cao; Xiaoqiang Ding
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.

Authors:  Daniel E Weiner; Luke Falzon; Line Skoufos; Angelito Bernardo; Werner Beck; Mengqi Xiao; Ha Tran
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-25       Impact factor: 8.237

9.  A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients.

Authors:  Gianluigi Zaza; Simona Granata; Federica Rascio; Paola Pontrelli; Maria Pia Dell'Oglio; Sharon Natasha Cox; Giovanni Pertosa; Giuseppe Grandaliano; Antonio Lupo
Journal:  BMC Med Genomics       Date:  2013-05-10       Impact factor: 3.063

10.  Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.

Authors:  Mark Reinhard; Jan Frystyk; Bente Jespersen; Mette Bjerre; Jens S Christiansen; Allan Flyvbjerg; Per Ivarsen
Journal:  BMC Nephrol       Date:  2013-04-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.